Sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate (U-63557A), a new, selective thromboxane synthase inhibitor: intravenous and oral pharmacokinetics in dogs and correlations with ex situ thromboxane B2 production.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Prostaglandins

• Publication date

  1983-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0090-6980(83)90098-9PMID 6685888
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate.

  1983cited by this paper
• Biology and biochemistry of thromboxane synthetase inhibitors.

  1983cited by this paper
• [41] A radioimmunoassay for thromboxane B2

  1982cited by this paper
• Thromboxane synthetase inhibition as antithrombotic strategy.

  1981cited by this paper
• Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase.

  1981cited by this paper
• Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.

  1981cited by this paper
• The prostanoids in hemostasis and thrombosis: a review.

  1980cited by this paper
• Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects.

  1980cited by this paper
• Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour.

  1980cited by this paper
• Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.

  1980cited by this paper
• Blood platelets do not provide endoperoxides for vascular prostacyclin production

  1979cited by this paper
• Arachidonate-induced platelet aggregation in the dog.

  1979cited by this paper
• Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.

  1978cited by this paper
• Measurement of prostaglandins, thromboxanes, prostacyclin and their metabolites by gas liquid chromatography--mass spectrometry.

  1978cited by this paper
• The role of lipids in platelet function: with particular reference to the arachidonic acid pathway.

  1978cited by this paper
• Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.

  1977cited by this paper
• Inhibitors of thromboxane synthase in human platelets

  1977cited by this paper
• Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane synthetase.

  1977cited by this paper
• Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes.

  1977cited by this paper
• A radioimmunoassay for thromboxane B2.

  1977cited by this paper
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

  1977cited by this paper
• Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.

  1977cited by this paper
• Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.

  1977cited by this paper
• Thromboxanes: selective biosynthesis and distinct biological properties.

  1976cited by this paper
• Radioimmunoassay for Thromboxane B2

  1976cited by this paper
• Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.

  1976cited by this paper
• Dog platelets fail to aggregate when they form aggregating substances upon stimulation with arachidonic acid.

  1976cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Biopharmaceutics and pharmacokinetics;: An introduction

  1971cited by this paper

• Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets

  2012cites this paper
• Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology.

  2008cites this paper
• Thromboxane synthase regulates the migratory phenotype of human glioma cells.

  1999cites this paper
• Altered Gene Expression in Human Astrocytoma Cells Selected for Migration: I. Thromboxane Synthase

  1998cites this paper
• Thromboxane is required for full expression of angiotensin hypertension in rats.

  1997cites this paper
• Inhibition of thromboxane synthesis attenuates insulin hypertension in rats.

  1997cites this paper
• A renal vasodilator effect of angiotensin II revealed by dual thromboxane inhibition.

  1994cites this paper
• Thromboxane synthase inhibition enhances furosemide-induced renal vasodilation.

  1993cites this paper
• Pulmonary hypertensive response to rabbit blood components in goats: role of thromboxane.

  1993cites this paper
• N-imidazolyl derivatives of the napththalene and chroman rings as thromboxane A2 synthase inhibitors

  1991cites this paper
• Recombinant human C5a-induced bronchoconstriction in the guinea-pig: a histamine independent mechanism.

  1990cites this paper
• C5a/C5ades-Arg-induced increase in blood pressure in the guinea pig: role of thromboxane.

  1990cites this paper
• Effects of thromboxane synthetase inhibition on patency and anastomotic hyperplasia of vascular grafts.

  1989cites this paper
• The protective effect of thromboxane synthetase inhibition on renal function in systemic sepsis.

  1989cites this paper
• The role of C5a in hypersensitivity reactions in the lung.

  1989cites this paper
• Thromboxane synthesis inhibitors and postprandial jejunal capillary exchange capacity.

  1988cites this paper
• Role of arachidonate metabolites in C5a-induced bronchoconstriction.

  1988cites this paper
• Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity.

  1987cites this paper
• Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney.

  1987cites this paper
• Thromboxane biosynthesis and its inhibition in man

  1987cites this paper
• Mediators of C5a-induced bronchoconstriction

  1987cites this paper
• Acute effect of a thromboxane synthetase inhibitor on renal function in unanaesthetized sheep.

  1987cites this paper
• Thromboxane synthesis inhibition and postprandial intestinal hyperemia and oxygenation.

  1986cites this paper
• Effect of thromboxane synthetase inhibition on canine autogenous vein grafts.

  1986cites this paper
• Thromboxane and prostacyclin in acute lung injury caused by venous air emboli in unanesthetized sheep.

  1986cites this paper
• Thromboxane Is Not Responsible for the High Pulmonary Vascular Resistance in Fetal Lambs

  1985cites this paper
• Effects of antiplatelet agents in combination with endothelial cell seeding on small-diameter Dacron vascular graft performance in the canine carotid artery model.

  1985cites this paper
• Liquid chromatographic-ultraviolet methods for furegrelate in serum and urine: preliminary pharmacokinetic evaluation in the dog.

  1985cites this paper
• Sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate (U-63557A) potentiates protective effect of intravenous eicosapentaenoic acid on impaired CBF in ischemic gerbils.

  1984cites this paper
• Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.

  1984cites this paper
• Development of a gas chromatographic-mass spectrometric method using a stable isotope internal standard for quantitation of thromboxane B2.

  1984cites this paper